Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions

A. Yankulov, A. Chapkanov, K. Mourdjev, A. Uchikov, D. Petrov (Plovdiv, Sofia, Bulgaria)

Source: Annual Congress 2012 - Chest wall, thoracic trauma and complications in thoracic surgery
Session: Chest wall, thoracic trauma and complications in thoracic surgery
Session type: Thematic Poster Session
Number: 2431
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Yankulov, A. Chapkanov, K. Mourdjev, A. Uchikov, D. Petrov (Plovdiv, Sofia, Bulgaria). Karnofsky score, pH and degree of pleural involvement as prognostic factors for survival in patients with malignant pleural effusions. Eur Respir J 2012; 40: Suppl. 56, 2431

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The survival prediction of malignant pleural effusion and the validation of LENT prognosis score in Thai patients.
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Histology, performance status and lymphopenia are factors of survival in patients undergoing thoracoscopy for malignant pleural effusion
Source: Annual Congress 2009 - Trends in bronchoscopy
Year: 2009


Prognostic significance of pleural tumour burden in patients with malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


Prognostic value of treatment outcomes patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Clinical and biological prognostic factors in malignant pleural effusion (MPE) secondary to breast cancer
Source: Annual Congress 2005 - What's new in the pleura
Year: 2005


Predictors of survival in patients with recurrent malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008


The presence of human mammaglobin transcripts in the pleural effusion is not predictive of survival in patients with malignant mesothelioma
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008


Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009


Is comorbidity a good prognostic factor for malignant pleural mesothelioma?
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008

Prognostic significance of neutrophil predominance in pleural fluid in patients with malignant effusion
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma
Source: Eur Respir J 2006; 28: Suppl. 50, 784s
Year: 2006

LENT Score: predicting the survival of malignant pleural effusion–a prospective study of three years
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012

Therapeutic outcome and prognostic factors in patients with pleural mesothelioma
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005

Is pleural VEGF a useful parameter?
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007


Prognostic factors in patients with malignant pleural effusion undergoing thoracoscopy
Source: Annual Congress 2011 - From outside to inside: access to the pleura
Year: 2011

Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


The value of IL6 in differentiation between malignant and non malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Malignant pleural mesothelioma (MPM): clinical presentation, complications and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002